Custom Designed Linker-Payload Synthesis And Bioconjugation Towards ADC Development

The success of an Antibody-Drug Conjugate (ADC) hinges on the quality and stability of its linker-payload construct. Custom synthesis of these complex molecules requires an efficient, integrated approach to accelerate your drug discovery and development timeline.

Discover a comprehensive strategy for linker-payload design, synthesis, and manufacturing that utilizes a toolbox approach to rapidly generate and evaluate new compounds. This integrated process includes a specialized bioconjugation team that can quickly attach novel constructs to antibodies, followed by rigorous ADC evaluation. Learn how this matrix evaluation and developability approach streamlines the scale-up and manufacture of challenging intermediates, offering GMP manufacturing services for preclinical, clinical, and commercial needs. See how decades of expertise can de-risk and accelerate your next ADC program.